In an update to treatment strategies for motor symptoms in early Parkinson disease, the American Academy of Neurology has reviewed the research on the benefits and risks of available medications.
Registry data show significant decreases in 14-day and 3-month case-fatality rates.
The sNDA submission is supported by data from a phase 3 trial that compared the efficacy and safety of fenfluramine with placebo in 263 patients aged 2 to 35 years with LGS.
The cumulative incidence of breast cancer recurrence was 8.5% at 15 years and 16.6% at 32 years.
People with familial hypercholesterolemia with COVID-19 risk endothelial dysfunction. Therapy should continue during the course of the virus.
Investigators assessed the association between diet quality and risk for and severity of COVID-19, as well as its relationship with socioeconomic deprivation.
The authors describe how to diagnose and treat Takotsubo syndrome in a patient with COVID-19.
Molnupiravir is an orally administered form of a ribonucleoside analogue that inhibits the replication of SARS-CoV-2.
An update to active surveillance recommendations has some physicians concerned.
In preclinical studies, CRV431 has been shown to reduce liver fibrosis and hepatocellular tumor burden.
Please login or register first to view this content.
